A study reveals Benralizumab as a new treatment for asthma and COPD, reducing treatment failure rates significantly.
Benralizumab is the first treatment for asthma attacks and chronic obstructive pulmonary disease (COPD) in 50 years. The ...
A clinical trial reveals that benralizumab, an injectable drug for severe asthma, outperforms steroids in reducing asthma and ...
A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and ...